Literature DB >> 6408117

A new serogroup (L) of Neisseria meningitidis.

F E Ashton, A Ryan, B Diena, H J Jennings.   

Abstract

A strain of neisseria meningitidis (LCDC 78189) isolated from the mother of a 3-year-old male with meningococcal meningitis was found to be antigenically distinct from the known serogroups A, B, C, D, H, I, K, X, Y, Z, 29E, and W135; it was designated serogroup L. Anti-78189 serum specifically agglutinated the homologous strain and three other strains which were isolated from the father and two other contacts of the child. Only those strains isolated from the contacts produced immunoprecipitates with the anti-78189 serum by the antiserum-agar method. A structurally unique capsular polysaccharide which was obtained from strain 78189 in a highly purified state was demonstrated to be the antigen responsible for the serological properties of the strain. The polysaccharide formed a precipitin band with the anti-78189 serum but not with the meningococcal grouping sera, and it was also able to absorb both the agglutinating and precipitating activity from the anti-78189 serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408117      PMCID: PMC272732          DOI: 10.1128/jcm.17.5.722-727.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Precipitation and carbohydrate-binding specificity studies on wheat germ agglutinin.

Authors:  I J Goldstein; S Hammarström; G Sundblad
Journal:  Biochim Biophys Acta       Date:  1975-09-09

2.  Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance.

Authors:  A K Bhattacharjee; H J Jennings; C P Kenny; A Martin; I C Smith
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

3.  Spread of meningococcal infection within households.

Authors:  R S Munford; A de E Taunay; J S de Morais; D W Fraser; R A Feldman
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

4.  Prevalence of meningococcal serogroups and description of three new groups.

Authors:  J R Evans; M S Artenstein; D H Hunter
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

5.  A new serological group (E) of Neisseria meningitidis.

Authors:  N A Vedros; J Ng; G Culver
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

6.  Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X.

Authors:  D R Bundle; I C Smith; H J Jennings
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

7.  Studies on the group-specific polysaccharide of Neisseria meningitidis serogroup X and an improved procedure for its isolation.

Authors:  D R Bundle; H J Jennings; C P Kenny
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

8.  Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide.

Authors:  T Y Liu; E C Gotschlich; F T Dunne; E K Jonssen
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

9.  Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide.

Authors:  T Y Liu; E C Gotschlich; E K Jonssen; J R Wysocki
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

10.  Meningococcal infections in Bolton, 1971-74.

Authors:  J S Farries; W Dickson; E Greenwood; T R Malhotra; J D Abbott; D M Jones
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

View more
  14 in total

1.  Neisseria meningitidis serogroup 29E (Z') septicemia in a patient with far advanced multiple myeloma (plasma cell leukemia).

Authors:  E Wachter; A E Brown; T E Kiehn; B J Lee; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

2.  New serogroups of Neisseria meningitidis isolated in the Federal Republic of Germany.

Authors:  U Berger
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

3.  Meningococcal infections.

Authors:  V K Wong; B Agee; K S Kim; H T Wright
Journal:  West J Med       Date:  1989-01

4.  Meningitis in a child due to Neisseria meningitidis group K.

Authors:  W D Grahlow; P Kuzemenská
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

5.  The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.

Authors:  Christa Litschko; Maria Rosaria Romano; Vittoria Pinto; Heike Claus; Ulrich Vogel; Francesco Berti; Rita Gerardy-Schahn; Timm Fiebig
Journal:  J Biol Chem       Date:  2015-08-18       Impact factor: 5.157

6.  Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.

Authors:  F Nato; J C Mazie; J M Fournier; B Slizewicz; N Sagot; M Guibourdenche; D Postic; J Y Riou
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Purification and characterization of polyphosphate kinase from Neisseria meningitidis.

Authors:  C R Tinsley; B N Manjula; E C Gotschlich
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic.

Authors:  P Kriz; J Vlckova; M Bobak
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

Review 9.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

10.  Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.

Authors:  L Spanjaard; P Bol; S de Marie; H C Zanen
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.